Registration

DLA PIPER LLP (US) for ELI LILLY & COMPANY

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmaceutical supply chain security and resiliency.

LobbyistCovered position, as disclosed
VANESSA JEANNE LE New Special Advisor and Special Counsel, Office of The Director of National Intelligence; Counsel, Senate Select Committee on Intelligence
MARGARET MARTIN New Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard Burr

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.